Microbiology & Infectious Diseases

A recent study at a Ryan White-funded clinic in the U.S. South highlights the effectiveness of long-acting antiretroviral therapies (LA-ART) in achieving viral suppression among individuals with HIV-1 viremia.

The bladder microbiomes of women diagnosed with gynecologic cancer are strikingly similar to those of women without such a diagnosis, according to new research.

A recent case study reveals a rare infection caused by Enterococcus cecorum, a bacterium typically associated with poultry, in a renal transplant recipient.

Cutaneous ulcers present a significant challenge in the management of chronic graft-versus-host disease (cGVHD), a complication that affects patients who have undergone allogeneic hematopoietic cell transplantation.

A newly developed DNA biochip offers a promising solution for the rapid screening of second-line drug resistance (SLDR) in Mycobacterium tuberculosis, offering faster detection and improved accuracy for multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB).

A groundbreaking dataset, the Antibiotic Resistance Microbiology Dataset (ARMD), has been developed to help combat antimicrobial resistance (AMR) by harnessing the power of electronic health records (EHRs).

Between November 2020 and June 2022, the United States conducted predeparture COVID-19 testing for nearly 24,000 refugees.

The growing body of research on the gut-skin axis and human microbiome has sparked increasing interest in microbiome-modulatory agents as potential treatments for acne vulgaris.